Origin Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,000
Closed -$498K 136
2021
Q1
$498K Sell
2,000
-200
-9% -$47.7K 0.05% 97
2020
Q4
$506K Hold
2,200
0.05% 90
2020
Q3
$559K Sell
2,200
-1,700
-44% -$421K 0.06% 80
2020
Q2
$920K Sell
3,900
-600
-13% -$137K 0.13% 72
2020
Q1
$912K Sell
4,500
-4,600
-51% -$1M 0.12% 76
2019
Q4
$2.19M Buy
+9,100
New +$2.01M 0.18% 84
2018
Q1
Sell
-49,205
Closed -$8.56M 116
2017
Q4
$8.56M Sell
49,205
-10,000
-17% -$1.77M 0.49% 67
2017
Q3
$11M Sell
59,205
-1,200
-2% -$213K 0.68% 53
2017
Q2
$10.4M Sell
60,405
-40,800
-40% -$6.64M 0.64% 52
2017
Q1
$16.6M Sell
101,205
-44,195
-30% -$7.34M 1.03% 35
2016
Q4
$21.3M Sell
145,400
-2,000
-1% -$301K 1.4% 26
2016
Q3
$24.6M Buy
+147,400
New +$24.9M 1.56% 23

Other funds holding AMGN

Origin Asset Management's AMGN Position: Q2 2021 in Review

Origin Asset Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 2,000 shares — an estimated $498K sold.

Origin Asset Management first reported a position in AMGN in Q3 2016 and held it in 12 quarters. The position peaked at $24.6M in Q3 2016. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Origin Asset Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Origin Asset Management sold 2,000 Amgen shares in Q2 2021, an estimated $498K.
  • Origin Asset Management first reported a position in Amgen in Q3 2016 and held it in 12 quarters.
  • Origin Asset Management's Amgen position peaked at $24.6M in Q3 2016.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Origin Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.